|
MannKind v Rea
|
|
Mannkind
|
Feb 08, 2013 05:12PM
|
|
MannKind's Afrezza And The Oramed Threat
|
|
Mannkind
|
May 23, 2013 08:36AM
|
|
Mannkind's Afrezza May Be Half As Effective As Current Injectable Insulins
|
|
Mannkind
|
Aug 15, 2013 01:26PM
|
|
MannKind's Countdown to Liftoff?
|
1
|
Mannkind
|
May 10, 2013 11:19AM
|
|
MannKind's Latest Data
|
|
Mannkind
|
Aug 15, 2013 04:46PM
|
|
MannKind: Good news coming?
|
3
|
Mannkind
|
Apr 17, 2013 09:47AM
|
|
MannKind: If You Buy, When?
|
|
Mannkind
|
Jun 27, 2012 09:29AM
|
|
MannKind: Will The Good News Ever Come?
|
|
Mannkind
|
Apr 25, 2012 08:53AM
|
|
MannKind: Year in Review
|
|
Mannkind
|
Dec 16, 2012 08:34AM
|
|
MannKind’s Afrezza Likely to Fail AFFINITY 1 Phase III Trial
|
1
|
Mannkind
|
Apr 11, 2013 10:12AM
|
|
MAP's Levadex Ready For FDA Approval
|
|
Mannkind
|
Feb 03, 2013 09:01AM
|
|
Margaret Hamburg
|
1
|
Mannkind
|
Mar 13, 2013 10:09AM
|
|
Marijuana Use Linked to Better Diabetes Stats
|
|
Mannkind
|
May 19, 2013 10:44AM
|
|
MARKET CURRENTS
|
1
|
Mannkind
|
Aug 27, 2012 12:17PM
|
|
Matt's speaking today
|
1
|
Mannkind
|
Sep 12, 2012 09:47AM
|
|
MBB, KTOS, CISG, SILU, DGICA, MNKD...
|
|
Mannkind
|
Dec 17, 2012 09:33AM
|
|
Merck and Abide to develop diabetes drugs in deal potentially worth $430M
|
|
Mannkind
|
May 03, 2013 10:28AM
|
|
Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MN
|
|
Mannkind
|
Mar 27, 2013 09:41AM
|
|
Method of preventing adverse effects by GLP-1
|
2
|
Mannkind
|
Feb 19, 2013 12:46PM
|
|
Michael Higgins on Biotech Names with Major Market Potential
|
1
|
Mannkind
|
Dec 20, 2012 03:25PM
|
